Government: Page
-
Where IVF benefits stand in the age of Trump
“Comprehensive fertility benefits, parental leave, and return to work support can make a meaningful difference to employees,” a senior principal in Mercer’s health and benefits team said.
By Ginger Christ • May 6, 2025 -
RFK’s FDA layoffs could slow safety communications, experts warn
The mass cuts, which included communications staff, could slow public notices on medical device recalls and other safety alerts.
By Elise Reuter • May 6, 2025 -
Explore the Trendline➔
Getty Images
TrendlineSurprise Billing
Federal legislation banning surprise bills has hit a barrage of roadblocks, complicating efforts to protect consumers from unexpected out-of-network charges.
By Healthcare Dive staff -
Trump orders FDA to help speed building of new drug factories
Yet regulatory relief for U.S. expansion could be accompanied by new tariffs and drug pricing rules.
By Jonathan Gardner • May 6, 2025 -
State attorneys general sue over ‘unconstitutional’ HHS restructuring
The lawsuit alleges the Trump administration overstepped its authority in reshaping the federal health department and asked the court to reinstate workers laid off last month.
By Susanna Vogel • May 6, 2025 -
Trump releases 2026 budget including heavy healthcare cuts
White House officials say the budget, which would slash the HHS’ discretionary funding by 26%, is necessary to curb government bloat. Medical groups say it amounts to an attack on biomedical funding and public health.
By Rebecca Pifer Parduhn • May 5, 2025 -
Democrats introduce resolution demanding transparency in HHS
The lawmakers are asking the Trump administration to reverse course on an HHS policy that breaks the longstanding practice of giving notice and accepting public comments about policy changes.
By Susanna Vogel • May 2, 2025 -
Deep Dive
Trump HHS tiptoes around endorsing conversion therapy for transgender minors
A new Trump administration report said teens struggling with gender dysphoria should undergo “exploratory” therapy and that conversion therapy was misunderstood.
By Susanna Vogel • May 2, 2025 -
DOJ accuses CVS, Humana, Elevance of paying kickbacks to Medicare Advantage brokers
According to the complaint, the insurers paid brokers eHealth, GoHealth and SelectQuote hundreds of millions of dollars for enrolling seniors in their MA coverage — regardless of the plans’ suitability for those members’ needs.
By Rebecca Pifer Parduhn • Updated May 2, 2025 -
Republican lawmakers urge CMMI to focus on cost savings, transparency
Lawmakers on the House Ways and Means Committee also accused CMMI of promoting “a political agenda,” like focusing on health equity and minimizing the importance of cost savings.
By Emily Olsen • April 30, 2025 -
Supreme Court rules against hospitals in DSH formula case
“The hospitals have lost at every stage of this litigation,” Justice Amy Coney Barrett wrote in the court’s majority opinion.
By Emily Olsen • April 30, 2025 -
Trump administration deploys DOJ, HHS in crackdown on youth gender-affirming care
The White House issued a fact sheet on Monday detailing its multi-agency push to reduce access to gender-affirming care for minors.
By Susanna Vogel • April 29, 2025 -
HHS sued again over cuts to public health grants
Municipalities in Texas, Tennessee, Ohio and Missouri, as well as a labor union, argue eliminating the funding would weaken their ability to respond to infectious disease outbreaks.
By Emily Olsen • April 29, 2025 -
Tracker
The Trump administration is overhauling healthcare policy. Follow the changes here.
The FDA said it’s sending letters to drugmakers demanding they take down or modify ads that don't comply with federal guidelines, out of concern consumers aren’t seeing a “fair balance” of risks and benefits in drug ads.
By Healthcare Dive staff • Updated Sept. 10, 2025 -
Top Republican calls for 340B reform in long-awaited investigation
Sen. Bill Cassidy’s report calls on Congress to improve program transparency, like requiring covered entities to show how they use 340B funds. Drug groups praised the findings, while hospitals argued the analysis was limited in scope.
By Emily Olsen • Updated April 28, 2025 -
Device developers advance AI plans despite Trump uncertainty
The Trump administration’s policies have raised questions about how the FDA will regulate AI in medical devices.
By Elise Reuter • April 24, 2025 -
CMS may be angling to reform Medicaid state directed payments
A new regulation pending in front of the Office of Management and Budget suggests the Trump administration may be moving to overhaul the controversial financing mechanism.
By Rebecca Pifer Parduhn • April 23, 2025 -
Walgreens to pay up to $350M in DOJ opioid settlement
The Justice Department alleged the pharmacy chain knowingly provided prescriptions for large amounts of opioids, filled prescriptions early and completed prescriptions for a dangerous combination of drugs.
By Emily Olsen • April 22, 2025 -
Dr. Oz sworn in as CMS administrator
During a ceremony at the Oval Office, Mehmet Oz said he would focus on reducing chronic disease, “modernizing” Medicare and Medicaid, and targeting fraud, waste and abuse in government insurance offerings.
By Emily Olsen • April 21, 2025 -
Arkansas passes law banning PBMs from owning pharmacies
The law in particular will affect CVS and UnitedHealth, both of which operate physical pharmacies in the state along with specialty and mail-order pharmacy businesses.
By Rebecca Pifer Parduhn • April 21, 2025 -
Head Start zeroed out in Trump’s preliminary budget plan
The early education program is among those targeted for closure in a budget draft for the HHS.
By Kara Arundel • April 17, 2025 -
HHS restructuring
Budget draft outlines Trump’s plan to slash federal health programs
An OMB document proposes to cut the HHS budget by roughly one-third as well as eliminate several divisions and programs.
By Sydney Halleman • April 17, 2025 -
Surescripts receives QHIN status under TEFCA
The addition of the e-prescribing giant’s information exchange brings the total number of Qualified Health Information Networks to nine.
By Emily Olsen • April 17, 2025 -
CMS rejects Humana’s Medicare Advantage star ratings appeal
The decision, which Humana disclosed in a Tuesday filing with the court overseeing its lawsuit against the HHS, will be reviewed by Dr. Mehmet Oz, the new CMS administrator.
By Rebecca Pifer Parduhn • April 16, 2025 -
Trump signals plan to address ‘pill penalty’ of drug pricing law
The president’s executive order promising to lower pharmaceutical prices includes support for a fix long sought by the industry, and could augur a new push for Medicare site neutrality.
By Kristin Jensen • April 16, 2025 -
Deep Dive
A judge blocked the FDA’s plan to regulate LDTs. What now?
One attorney said the ruling “isn’t quite the stake in the heart.” The FDA is unlikely to challenge the court’s decision, but Congress could still pass legislation addressing LDT regulation
By Susan Kelly • April 16, 2025